Resolution of Paraneoplastic Cutaneous Angioendotheliomatosis After CAR T‐Cell Therapy in TP53‐Deleted CLL: A Case Report
Feras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan‐Dabaja · 2026
Read Resolution of Paraneoplastic Cutaneous Angioendotheliomatosis After CAR T‐Cell Therapy in TP53‐Deleted CLL: A Case Report by Feras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan‐Dabaja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13421918.txt.
Description
Alfraih and colleagues describe in this 2026 case report a skin disorder that melted away after cellular immunotherapy aimed at leukemia. Their patient was a 58-year-old man with high-risk chronic lymphocytic leukemia carrying a TP53 mutation and chromosome deletion, who developed rapidly growing, fungating skin lesions despite five earlier lines of treatment.
Biopsy showed reactive angioendotheliomatosis, a rare benign proliferation of blood vessels inside the skin, with no leukemia cells present in the lesions. Local care failed, but after CD19-directed CAR T-cell therapy with lisocabtagene maraleucel, engineered immune cells that hunt B cells, the skin lesions regressed markedly. Oddly, his leukemia still showed measurable residual disease and later relapsed systemically, requiring a transplant. The authors read the skin cure as immune modulation by the therapy, not direct killing of tumor in the skin.
Catalog record
| CREATOR | Feras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan‐Dabaja |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |